Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices
- PMID: 2389680
- DOI: 10.1007/BF00308919
Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices
Abstract
Proliferation indices and mean number of silver-stained nucleolar organizer region-associated proteins (Ag-NORs) are compared in 65 brain tumors, including 34 gliomas, 8 meningiomas, 17 metastatic tumors, and 6 other tumors. Immunocytochemical investigations include labeling with the monoclonal antibody Ki-67 which identifies the whole growth fraction, and with a monoclonal antibody against bromodeoxyuridine (BrdUrd) which detects cells in the S phase of the cell cycle after in vitro incubation with BrdUrd. When all types of tumors are collectively considered, mean numbers of Ag-NORs did not correlate with Ki-67 and Brd-Urd labeling indices (LIs) and mitotic index. Among tumor subtypes, only meningiomas showed significant correlations between Ag-NOR counts, LIs, and malignancy. Mean number of Ag-NORs did not correlate with proliferation indices and tumor grade in low-grade and high-grade gliomas. However, recurrent high-grade gliomas showed a tendency to higher Ag-NOR counts than primary tumors. This study indicates that counting of Ag-NORs in paraffin sections is of limited value in tumor neuropathology. Correlations found in meningeal tumors should be substantiated in larger series.
Similar articles
-
Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.Acta Neuropathol. 1993;86(6):582-9. doi: 10.1007/BF00294296. Acta Neuropathol. 1993. PMID: 7906072
-
[Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human central nervous tumors].Rinsho Byori. 1992 Nov;40(11):1179-84. Rinsho Byori. 1992. PMID: 1284911 Japanese.
-
Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.Acta Neurochir (Wien). 1991;109(1-2):37-41. doi: 10.1007/BF01405695. Acta Neurochir (Wien). 1991. PMID: 1648862
-
Neuropathology, cell biology, and newer diagnostic methods.Curr Opin Oncol. 1993 May;5(3):441-9. doi: 10.1097/00001622-199305000-00002. Curr Opin Oncol. 1993. PMID: 8494905 Review.
-
The application of 5-bromodeoxyuridine in the management of CNS tumors.J Neurooncol. 1994;20(1):81-95. doi: 10.1007/BF01057964. J Neurooncol. 1994. PMID: 7807187 Review.
Cited by
-
Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.J Neurooncol. 2002 Apr;57(2):105-14. doi: 10.1023/a:1015705305540. J Neurooncol. 2002. PMID: 12125970
-
No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.J Neurooncol. 1997 Sep;34(3):241-6. doi: 10.1023/a:1005794700267. J Neurooncol. 1997. PMID: 9258816
-
Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.Acta Neuropathol. 1993;86(6):582-9. doi: 10.1007/BF00294296. Acta Neuropathol. 1993. PMID: 7906072
-
Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.Neurosurg Rev. 2003 Jul;26(3):221-8. doi: 10.1007/s10143-003-0261-1. Epub 2003 Apr 8. Neurosurg Rev. 2003. PMID: 12690530
-
The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.J Neurooncol. 1998 Mar;37(1):9-16. doi: 10.1023/a:1005905009449. J Neurooncol. 1998. PMID: 9525833
References
MeSH terms
Substances
LinkOut - more resources
Medical